000 01716 a2200457 4500
005 20250517112559.0
264 0 _c20171010
008 201710s 0 0 eng d
022 _a1879-114X
024 7 _a10.1016/j.clinthera.2016.07.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLugogo, Njira
245 0 0 _aLong-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study.
_h[electronic resource]
260 _bClinical therapeutics
_cSep 2016
300 _a2058-2070.e1 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdministration, Intravenous
650 0 4 _aAdrenal Cortex Hormones
_xtherapeutic use
650 0 4 _aAnti-Asthmatic Agents
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadministration & dosage
650 0 4 _aAsthma
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aEosinophilia
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aGlucocorticoids
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aYoung Adult
700 1 _aDomingo, Christian
700 1 _aChanez, Pascal
700 1 _aLeigh, Richard
700 1 _aGilson, Martyn J
700 1 _aPrice, Robert G
700 1 _aYancey, Steven W
700 1 _aOrtega, Hector G
773 0 _tClinical therapeutics
_gvol. 38
_gno. 9
_gp. 2058-2070.e1
856 4 0 _uhttps://doi.org/10.1016/j.clinthera.2016.07.010
_zAvailable from publisher's website
999 _c26353781
_d26353781